The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
Osteosarcoma (OS) is a malignant tumor with an extremely poor prognosis, especially in progressive patients. Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment option for OS. Due to tumor heterogeneity, only a minority of patients benefit from immuno...
Saved in:
Main Authors: | Yu Chen, Wei Yan, Hongqing Wang, Zhiliang Ou, Huihong Chen, Zhenhua Huang, Jinlian Yang, Biqiong Liu, Fanjie Ou, Huang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/6563609 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01) -
Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
by: Yang Zhou, et al.
Published: (2022-01-01) -
Immunotherapy of osteosarcoma based on immune microenvironment modulation
by: Heping Lian, et al.
Published: (2025-01-01) -
Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma
by: Shunhan Yao, et al.
Published: (2022-01-01) -
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
by: Gui-Qi Zhu, et al.
Published: (2025-01-01)